The expression of NFKBIZ (a nuclear inhibitor of NF-κB) in keratinocytes has been found to trigger not only skin lesions but also systemic inflammation in mouse psoriasis models (Lorscheid et al., 2019). This evidence concerns the gene NFKB1 and psoriasis.